Lombard Odier Asset Management Switzerland SA Acquires 6,366 Shares of Cardinal Health, Inc. $CAH

Lombard Odier Asset Management Switzerland SA grew its holdings in Cardinal Health, Inc. (NYSE:CAH) by 37.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 23,407 shares of the company’s stock after buying an additional 6,366 shares during the period. Lombard Odier Asset Management Switzerland SA’s holdings in Cardinal Health were worth $3,932,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Counterpoint Mutual Funds LLC acquired a new stake in Cardinal Health during the second quarter worth approximately $1,911,000. Atlantic Union Bankshares Corp bought a new stake in shares of Cardinal Health during the 2nd quarter valued at $79,000. Marshall Wace LLP grew its holdings in shares of Cardinal Health by 19.1% during the 2nd quarter. Marshall Wace LLP now owns 1,930,967 shares of the company’s stock worth $324,402,000 after purchasing an additional 309,335 shares in the last quarter. KLP Kapitalforvaltning AS grew its holdings in shares of Cardinal Health by 4.0% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock worth $19,185,000 after purchasing an additional 4,400 shares in the last quarter. Finally, Acadian Asset Management LLC increased its position in shares of Cardinal Health by 92.5% in the second quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock worth $282,063,000 after purchasing an additional 807,063 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Price Performance

CAH stock opened at $198.01 on Wednesday. The stock has a market cap of $47.05 billion, a price-to-earnings ratio of 29.87, a P/E/G ratio of 1.45 and a beta of 0.63. The company has a 50 day simple moving average of $184.29 and a 200 day simple moving average of $165.86. Cardinal Health, Inc. has a 1 year low of $114.60 and a 1 year high of $214.93.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company’s quarterly revenue was up 22.4% on a year-over-year basis. During the same quarter last year, the business posted $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be given a dividend of $0.5107 per share. The ex-dividend date is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s payout ratio is currently 30.77%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Evercore ISI upped their price target on shares of Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a report on Friday, October 31st. Wells Fargo & Company lifted their price objective on shares of Cardinal Health from $185.00 to $221.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Jefferies Financial Group set a $220.00 price objective on shares of Cardinal Health and gave the company a “buy” rating in a research report on Monday, November 3rd. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and an average price target of $209.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.